Pregnancy

Exposure to beta-blockers during the third trimester of pregnancy may increase the risk for bradycardia, hypoglycemia, hypotension, and respiratory depression in the neonate. Newborns should be monitored and managed accordingly. If maternal use of a beta-blocker is needed, fetal growth should be monitored during pregnancy and the newborn should be monitored for 48 hours after delivery for bradycardia, hypoglycemia, and respiratory depression

Lactation

In general, propranolol may be compatible with breastfeeding when used at usual doses. Breastfeeding infants should be monitored for bradycardia, cyanosis, and hypoglycemia

Warnings

"Contraindicated: cardiogenic shock, sinus bradycardia, bronchial asthma, hypersensitivity Warnings: Angina pectoris, nonallergic bronchospasm, thyrotoxicosis, hypoglycemia"